CHRISTI SHAW

CEO Kite Pharmaceuticals

Ms. Shaw oversees all aspects of cell therapy at Gilead’s Kite business unit, with responsibility for all of the company’s 1,200 employees around the world.

Ms. Shaw has over 25 years of experience providing commercial, financial, strategic, medical, clinical development, legal and operations leadership in healthcare.

Ms. Shaw joined Kite from Eli Lilly & Company, where she served as senior vice president, Eli Lilly & Company and president, Lilly Bio-Medicines, leading the company’s broadest therapeutic portfolio and overseeing late-stage clinical development and commercialization.

Ms. Shaw has held prominent leadership roles at Lilly, Johnson & Johnson and Novartis where she served as US Country President and President 2016.

Ms. Shaw has been recognized with numerous industry awards including: a 2019 Women in Oncology Award (PRIMO), a 2018 Health Visionary Award (Society for Women’s Health Research) and a 2016 Lifetime Achievement Award (Eye for Pharma), among others.

Ms. Shaw currently serves on the boards of the Biotechnology Industry Organization; Avantor, a global manufacturer and distributor of products, services and solutions to professionals in the life sciences and advanced technology industries; and the Healthcare Women’s Business Association. She serves as an Advisor to Concord Health Partners. In 2017, she founded the More Moments More Memories Foundation to assist people with cancer and their caregivers.

Ms. Shaw earned a Master of Business Administration from the University of Wisconsin and a Bachelor of Business Administration from Iowa State University.